The effects of calcium-regulating-hormone on BMC in patients with CRF

Abstract

By means of single photon absorptiometry, bone material content (BMC) on centerbrachium was detected in 34 patients with chronic renal failure (CRF) and 34 sex-age-matched normal controls, and their serum parathyroid hormone (PTH), calcitonin (CT) were also measured by radioimmunoassay. It was found that (1) the mean BMC was obviously lower in patients with CRF than that in the normal controls; (2) PTH and CT obviously rose in patients with CRF; (3) the decrease of BMC was strongly correlated with that of creatinine clearance (Ccr). Furthermore, the more Ccr decreases, the more PTH in blood increases; no relations have been found between BMC and the serum levels of CT. The authors suggest that the development of osteoporosis with CRF is due to the secondary increase of PTH in blood but the effect of increased serum CT levels was not so obvious. Therefore, lowering blood PTH concentrations by parathyroidectomy or renal transplantation may be beneficial to curing osteoporosis of patients with CRF.

Keywords

osteoporosis / CRF / PTH / CT

References

[1] 1987; 773–783

[2] 1990; 6 (5): 317

[3] CameronJ R, SorensonJ. Measurement of bone mineral in vivo: an improved method. Science, 1963, 142: 230-230

[4] RiggsB L, MeltonL J. Medical progress series: Involution Osteoporosis. N Eng Med, 1986, 314: 1676-1676

[5] McCarthyJ T, KleG G, KaoP C. Serum bioactive parathyroid hormone in hemodialysis patients. J clin End crubot Metab, 1989, 69(2): 340-340

[6] KeyeM, D’AmourP. Henderson. Elective total parathyroidertomy without autotransplant in end-stage renal disease. Kidney int, 1989, 35(6): 1390-1390

[7] D’AngelA, BcnucciE, GianninzS. Evogenous calcibonin protects against renal bone disease in rats with early renal failure. Bone miner, 1987, 3(2): 171-171

[8] MulderH, SicberbuschI, HackengW H L. Enhanced Calcitonin Release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism. Nephron, 1982, 31: 123-123